Reported covered position: SENATE FINANCE COMMITTEE - HEALTH POLICY ADVISOR AND COUNSEL
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Patient Access to Hospice Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
Source: Senate LDA
| MASSACHUSETTS HOSPITAL ASSOCIATION |
| 27 |
| 2005–2017 |
| GREATER NEW YORK HOSPITAL ASSOCIATION | 25 | 2009–2017 |
| PREMIER, INC. | 25 | 2009–2017 |
| HOLOGIC, INC. | 23 | 2010–2017 |
| ROHO GROUP | 23 | 2005–2013 |
| ERICKSON RETIREMENT COMMUNITIES | 20 | 2008–2013 |
| HEALTH MANAGEMENT ASSOCIATES | 18 | 2006–2013 |
| CSL BEHRING LLC (FORMERLY ZLB BEHRING) | 16 | 2005–2010 |
| GENENTECH INC | 16 | 2011–2012 |
| ATHENAHEALTH | 13 | 2010–2012 |
| CELGENE CORPORATION | 13 | 2010–2013 |
| NOVO NORDISK, INC. | 13 | 2014–2017 |
| ABBOTT LABORATORIES | 12 | 2004–2009 |
| ENDO PHARMACEUTICALS | 12 | 2010–2013 |
| HEALTHWAYS | 11 | 2015–2017 |
| HUMACYTE, INC. | 11 | 2015–2017 |
| OTP CONSORTIUM | 11 | 2015–2017 |
| AETNA, INC. | 10 | 2009–2011 |
| ALLIANCE FOR QUALITY NURSING HOME CARE | 10 | 2004–2008 |
| AMERICAN HEALTH QUALITY ASSOCIATION | 10 | 2010–2012 |
| NOVARTIS CORPORATION | 10 | 2015–2017 |
| AMERICAN ASSN FOR HOMECARE | 9 | 2004–2006 |
| COALITION OF FULL SERVICE COMMUNITY HOSPITALS | 9 | 2005–2008 |
| TENNESSEE HOSPITAL ASSOCIATION | 9 | 2005–2008 |
| VERAX BIOMEDICAL | 9 | 2015–2017 |
| VISION SERVICE PLAN | 9 | 2007–2012 |
| CAREFUSION | 8 | 2009–2011 |
| LIFESCAN, INC. | 8 | 2006–2009 |
| HEARING INDUSTRIES ASSOCIATION | 7 | 2015–2016 |
| NATIONAL CARDIOVASCULAR PARTNERS | 7 | 2016–2017 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION | 7 | 2006–2008 |
| ROCHE DIAGNOSTICS | 7 | 2006–2009 |
| ALMOST FAMILY | 6 | 2011–2012 |
| AMERICAN CHIROPRACTIC ASSN | 6 | 2004–2005 |
| BAYER HEALTHCARE | 6 | 2006–2009 |
| CONTINUA HEALTH ALLIANCE | 6 | 2009–2010 |
| CVS CAREMARK INC (FORMERLY CAREMARK RX INC ) | 6 | 2004–2006 |
| DES MOINES UNIVERSITY | 6 | 2009–2010 |
| DEY, L.P. | 6 | 2009 |
| IOWA HEALTH SYSTEM | 6 | 2009–2010 |
| LHC GROUP INC. | 6 | 2008 |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS | 6 | 2011–2012 |
| PARTNERSHIP FOR QUALITY HOME HEALTHCARE | 6 | 2016–2017 |
| PHAROS INNOVATIONS | 6 | 2009–2010 |
| NATIONAL ASSOCIATION FOR BEHAVIORAL HEALTH | 5 | 2008–2009 |
| SOCIETY OF INTERVENTIONAL RADIOLOGY | 5 | 2011–2012 |
| ADVOCATE HEALTHCARE | 4 | 2005–2007 |
| AMERIPATH | 4 | 2004 |
| AVENTIS PHARMACEUTICALS | 4 | 2004 |
| CHEYENNE INTERNATIONAL, LLC | 4 | 2006–2007 |
| EHEALTHINSURANCE | 4 | 2004 |
| MYLAN LABORATORIES | 4 | 2004–2008 |
| NDCHEALTH CORP | 4 | 2004–2005 |
| WASHINGTON2 ADVOCATES | 4 | 2004 |
| AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS | 3 | 2012–2013 |
| EDUCAP, INC. | 3 | 2007 |
| FORD MOTOR CO | 3 | 2004–2005 |
| PRAECIS PHARMACEUTICALS | 3 | 2004–2005 |
| US ONCOLOGY INC | 3 | 2006–2007 |
| US PHARMACOPEIA | 3 | 2004–2005 |
| VITAS HEALTHCARE CORPORATION | 3 | 2005–2007 |
| ADAMS LABORATORIES | 2 | 2004 |
| ASSURANT INC (F/K/A FORTIS INC ) | 2 | 2004 |
| BNN HOLDINGS CORP | 2 | 2013 |
| CORDUS CORPORATION | 2 | 2005 |
| Chemed Corporation | 2 | 2007 |
| HERITAGE PROVIDER NETWORKS | 2 | 2004–2005 |
| JEROME STEVENS PHARMACEUTICALS | 2 | 2004 |
| PARAMOUNT CAPITAL INC | 2 | 2004 |
| PROVIDENCE PLAN | 2 | 2005 |
| UNITED HEALTH SERVICES - PRUITT CORPORATION | 2 | 2015 |
| ASSN OF HIP & KNEE SURGEONS | 1 | 2007 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 1 | 2008 |
| BRACCO DIAGNOSTICS INC. | 1 | 2007 |
| COMMUNITY HEALTH ADVOCATES | 1 | 2006 |
| CONEXIS | 1 | 2009 |
| COVENANT HEALTHCARE HOSPITAL | 1 | 2007 |
| FLORIDA MEDICAL ASSOCIATION | 1 | 2007 |
| FUNDAMENTAL HEALTH | 1 | 2007 |
| HEALTHTRAC INC | 1 | 2007 |
| INGHAM REGIONAL MEDICAL CENTER & SPARROW HEALTH SYSTEM | 1 | 2006 |
| MATRIX MEDICAL NETWORK | 1 | 2015 |
| MERCK & COMPANY INC | 1 | 2006 |
| MISSOURI HOSPITAL ASSOCIATION | 1 | 2006 |
| NATIONSHEALTH | 1 | 2010 |
| POSIT SCIENCE CORPORATION | 1 | 2007 |
| ROBINSON MANUFACTURING COMPANY | 1 | 2005 |
| TRAVERE THERAPEUTICS | 1 | 2016 |
| VIANT HEALTH PAYMENT SOLUTIONS | 1 | 2008 |
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Medicare Patient Access to Hospice Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Medicare Patient Access to Hospice Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Rural Access to Hospice Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Rural Access to Hospice Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Rural Access to Hospice Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Rural Access to Hospice Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 1953 and S. 830 Treat and Reduce Obesity Act; Medicare diabetes screening generally.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Home Health Documentation and Program Improvement Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Home Health Documentation and Program Improvement Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; cost of diabetes generally; H.R. 309, National Clinical Care Commission Act.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: FRESENIUS MEDICAL CARE · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: FRESENIUS MEDICAL CARE · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Preserve Access to Medicare Rural Home Health Services Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Preserve Access to Medicare Rural Home Health Services Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Preserve Access to Medicare Rural Home Health Services Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Preserve Access to Medicare Rural Home Health Services Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Home Health Care Planning Improvement Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Home Health Care Planning Improvement Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Home Health Care Planning Improvement Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Home Health Care Planning Improvement Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017
Client: HEALTHWAYS · Firm: ALSTON & BIRD LLP
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46 the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017
Client: HEALTHWAYS · Firm: ALSTON & BIRD LLP
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46 the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017
Client: HEALTHWAYS · Firm: ALSTON & BIRD LLP
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017
Client: HEALTHWAYS · Firm: ALSTON & BIRD LLP
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 1953 and S. 830 Treat and Reduce Obesity Act; Medicare diabetes screening generally.
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
No Raise for Congress Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
No Raise for Congress Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
No Raise for Congress Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
No Raise for Congress Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
PUSH Act of 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
PUSH Act of 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
PUSH Act of 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
PUSH Act of 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
2017 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2017 · second_quarter · 2T
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
OTP CONSORTIUM via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Coverage and payment issues related to outpatient cardiology services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017; S.870, the CHRONIC Care Act of 2017 and H.R.2663, Home Health Documentation and Program Improvement Act of 2017.
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2017 · second_quarter · Q2
General legislative and regulatory issues related to Medicare and Medicaid; Monitor and analyze issues related to Medicare and Medicaid.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2017 · second_quarter · 2T
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
HUMACYTE, INC. via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HEALTHWAYS via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46 the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2017 · second_quarter · 2T
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2017 · second_quarter · 2T
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2017 · second_quarter · Q2
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs; physician burden reduction under Medicare, in general.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 1953 and S. 830 Treat and Reduce Obesity Act; Medicare diabetes screening generally.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; cost of diabetes generally; H.R. 309, National Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2017 · first_quarter · Q1
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
OTP CONSORTIUM via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Veterans Affairs, Dept of (VA)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
Issues relating to home health care and hospice, including post-acute payment policy; H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015; H.R.2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; H.R.3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; S.445, Home Health Care Planning and Improvement Act of 2017; H.R.6226, Pre-Claims Undermine Seniors Health Act of 2016; S.353, Preserve Access to Medicare Rural Home Health Services Act of 2017; H.R.1284, Medicare Patient Access to Hospice Act of 2017; H.R.1828, Rural Access to Hospice Act of 2017.
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
General legislative and regulatory issues related to Medicare and Medicaid; Monitor and analyze issues related to Medicare and Medicaid.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2017 · first_quarter · Q1
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
HUMACYTE, INC. via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HEALTHWAYS via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46 the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S.46, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2017 · first_quarter · Q1
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2017 · first_quarter · Q1
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; H.R. 1331, the Electronic Health Record Improvement Act; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures legislation & Senate Companion Bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; H.R. 6, 21st Century Cures Act.
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; Issues related to H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; Issues related to H.R. 513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; Issues related to H.R. 1342, Home Health Care Planning and Improvement Act of 2015; Issues related to H.R. 6226, Pre-Claims Undermine Seniors Health Act of 2016.
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; Issues related to H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; Issues related to H.R. 513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; Issues related to H.R. 1342, Home Health Care Planning and Improvement Act of 2015; Issues related to H.R. 6226, Pre-Claims Undermine Seniors Health Act of 2016.
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
General legislative and regulatory issues related to Medicare and Medicaid; Monitor and analyze issues related to Medicare and Medicaid.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HEARING INDUSTRIES ASSOCIATION via ALSTON & BIRD LLP
2016 · fourth_quarter · 4T
Issues related to hearing health accessibility and affordability for adults.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHWAYS via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S. 2382, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2015.
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S. 2382, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures Act and related Senate companion bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; H.R. 1320/S. 608, the Supported Colorectal Examination and Education Now Act (SCREEN Act) of 2013; H.R. 1331, the Electronic Health Record Improvement Act; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2016 · fourth_quarter · RR
Issues related to S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016.
Issues related to S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016.
Issues related to S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016.
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures legislation & Senate Companion Bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · third_quarter · Q3
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via ALSTON & BIRD LLP
2016 · third_quarter · Q3
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; Issues related to H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; Issues related to H.R. 513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; Issues related to H.R. 1342, Home Health Care Planning and Improvement Act of 2015.
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation; Issues related to H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act of 2015; Issues related to H.R. 513, Sustaining Health Care Integrity and Fair Treatment Act of 2016; Issues related to H.R. 1342, Home Health Care Planning and Improvement Act of 2015.
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
General legislative and regulatory issues related to Medicare and Medicaid; Monitor and analyze issues related to Medicare and Medicaid.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · third_quarter · Q3
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HEARING INDUSTRIES ASSOCIATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to hearing health accessibility and affordability for adults.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHWAYS via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S. 2382, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2015.
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S. 2382, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures Act and related Senate companion bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2016 · third_quarter · Q3
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2016 · third_quarter · Q3
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; H.R. 1320/S. 608, the Supported Colorectal Examination and Education Now Act (SCREEN Act) of 2013; H.R. 1331, the Electronic Health Record Improvement Act; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures legislation & Senate Companion Bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · second_quarter · Q2
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
General legislative and regulatory issues related to Medicare and Medicaid; Monitor and analyze issues related to Medicare and Medicaid.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · second_quarter · Q2
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HEARING INDUSTRIES ASSOCIATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to hearing health accessibility and affordability for adults.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHWAYS via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S. 2382, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2015.
Issues related to the intensive cardiac rehabilitation program & wellness programs, including S. 2382, the Strengthening Medicare Intensive Cardiac Rehabilitation Programs Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures Act and related Senate companion bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2016 · second_quarter · Q2
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2016 · second_quarter · Q2
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; H.R. 1320/S. 608, the Supported Colorectal Examination and Education Now Act (SCREEN Act) of 2013; H.R. 1331, the Electronic Health Record Improvement Act; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · second_quarter · RR
Issues affecting Medicare-certified home health agencies (HHAs); activities and programs of the Centers for Medicare and Medicaid Services (CMS).
Issues affecting Medicare-certified home health agencies (HHAs); activities and programs of the Centers for Medicare and Medicaid Services (CMS).
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2017 Payment Rates.
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2017 Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues regarding group purchasing organizations and delivery reform; 21st Century Cures legislation & Senate Companion Bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · first_quarter · Q1
General legislative and regulatory issues related to Medicare and Medicaid; Monitor and analyze issues related to Medicare and Medicaid.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · first_quarter · Q1
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Medicare diabetes screening generally; H.R. 2005 and S. 1083 Medicare Drug Savings Act of 2015.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Medicare diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE